Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD-positive blood products in trauma

Transfusion. 2023 May;63 Suppl 3:S4-S9. doi: 10.1111/trf.17352. Epub 2023 Apr 18.
No abstract available

Keywords: RhD; hemolytic disease of the fetus and newborn; low titer group O whole blood; massive bleeding; mismatch; red blood cell; safety; trauma; women.

MeSH terms

  • Erythroblastosis, Fetal*
  • Female
  • Humans
  • Infant, Newborn
  • Rh-Hr Blood-Group System


  • Rh-Hr Blood-Group System